Clinical Trial Update: The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid on Lipid Profile in Fibrate Treated Patients. [Phase 3]

View source ↗

Summary

Phase 3 study evaluating Dunaliella bardawil extract as a source of 9-cis retinoic acid to modify lipid profiles in fibrate-treated patients; the trial status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• Dunaliella bardawil extract (source of 9-cis retinoic acid) (9-cis retinoic acid)

Snippet

Sponsor: Sheba Medical Center | Conditions: Low HDL Cholesterol | Phase 3 | Status: COMPLETED